Publications by authors named "Susan Yost"

Claim this Profile
S
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial.
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, Paul H Frankel, Susan E Yost

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I Trial.
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, Paul H Frankel, Susan E Yost

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy.
Isaac Bishara, Patrick A Cosgrove, Sumana Majumdar, Colt A Egelston, Oscar Colunga Flores, Susan E Yost

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Actionability of Molecular Targets in Multi-Ethnic Breast Cancer Patients: A Retrospective Single-Institutional Study.
Irene Kang, Leah Naghi, Susan E Yost, Joanne Mortimer

Mol Diagn Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate.
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, Paul H Frankel, Nora Ruel, Susan E Yost

Antioxidants (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial.
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, Paul H Frankel, Susan E Yost

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCA4 / BRG1 -deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4 -driven Gynecologic Malignancies.
Christina H Wei, Evita Sadimin, Mark Agulnik, Susan E Yost, Teri A Longacre

Int J Gynecol Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche.
Martha Zepeda-Rivera, Samuel S Minot, Heather Bouzek, Hanrui Wu, Aitor Blanco-Míguez, Susan C Yost

Nature· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Chronic Graft-versus-Host Disease in Post-Hematopoietic Stem Cell Transplant Patients Following SARS-CoV-2 Vaccination: Case Reports.
Joel B Epstein, Raymond S Hernandez, Ryotaro Nakamura, Susan E Yost, Haris Ali

Case Rep Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.
Yuan Yuan, Colt Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Lin, Susan E Yost

Ther Adv Med Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Colt A Egelston, Weihua Guo, Susan E Yost, Xuan Ge, Jin Sun Lee

Cancer Immunol Immunother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer.
Xuan Ge, Carolyn E Behrendt, Susan E Yost, Niki Patel, Raynald Samoa

Oncologist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
Yuan Yuan, Susan E Yost, Yujie Cui, Christopher Ruel, Mireya Murga

Oncologist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute.
Christina H Wei, Susan Shehayeb, Nicole Lugo Santiago, Laura Kruper, Ernest Han, Susan E Yost

PLoS One· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication-Related Osteonecrosis of the Jaw: Successful Medical Management of Complex Maxillary Alveolus with Sinus Involvement.
Joel B Epstein, Praveen R Arany, Susan E Yost, Yuan Yuan

Case Rep Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Sayeh M Lavasani, George Somlo, Susan E Yost, Paul H Frankel, Christopher Ruel

Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer.
Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Susan E Yost

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Xuan Ge, Susan E Yost, Jin Sun Lee, Paul H Frankel, Christopher Ruel

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer.
Kyung-Min Lee, Chang-Ching Lin, Alberto Servetto, Joonbeom Bae, Vishal Kandagatla, Susan E Yost

Cancer Immunol Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and epigenomic alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas.
Francesca Menghi, Kalyan Banda, Pooja Kumar, Robert Straub, Lacey Dobrolecki, Susan E Yost

Sci Transl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth.
Minghui Cao, Roi Isaac, Wei Yan, Xianhui Ruan, Li Jiang, Susan E Yost

Nat Cell Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.
Jin Sun Lee, Susan E Yost, Sierra Min Li, Yujie Cui, Paul H Frankel

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
Yuan Yuan, Jin Sun Lee, Susan E Yost, Paul H Frankel, Christopher Ruel

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome.
Juliana C Wortman, Ting-Fang He, Shawn Solomon, Robert Z Zhang, Anthony Rosario, Susan E Yost

NPJ Breast Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.
Moom R Roosan, Isa Mambetsariev, Rebecca Pharaon, Jeremy Fricke, Angel R Baroz, Susan E Yost

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis